These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8686196)

  • 21. Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?
    Hudson M; Richard H; Pilote L
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):773-85. PubMed ID: 17486661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].
    Arós F; Loma-Osorio A; Vila J; López-Bescós L; Cuñat J; Rodríguez E; San José JM; Heras M; Marrugat J;
    Rev Esp Cardiol; 2006 Apr; 59(4):313-20. PubMed ID: 16709383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management after a first myocardial infarction.
    Flapan AD
    Hosp Pract (1995); 1996 May; 31(5):133-7, 141-6. PubMed ID: 8632043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
    Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Reduction in acute myocardial infarction mortality over a five-year period].
    Heras M; Marrugat J; Arós F; Bosch X; Enero J; Suárez MA; Pabón P; Ancillo P; Loma-Osorio A; Rodríguez JJ; Subirana I; Vila J;
    Rev Esp Cardiol; 2006 Mar; 59(3):200-8. PubMed ID: 16712743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes, hypertension, and renal insufficiency in post-myocardial infarction cardiovascular risk.
    Abraham WT
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S30-6. PubMed ID: 14564232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Drug therapy in the secondary prevention of atherosclerosis].
    Kettunen R
    Duodecim; 2002; 118(20):2093-101. PubMed ID: 12463000
    [No Abstract]   [Full Text] [Related]  

  • 28. ACE inhibitors in acute myocardial infarction.
    Murdoch DR; McMurray JJ
    Hosp Med; 1998 Feb; 59(2):111-5. PubMed ID: 9797884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute myocardial infarction care improved, but still inadequate.
    Rollins G
    Rep Med Guidel Outcomes Res; 2003 Aug; 14(15):1-2, 5. PubMed ID: 12964576
    [No Abstract]   [Full Text] [Related]  

  • 30. [Basic program of myocardial infarct after-care].
    Holtz H
    Z Gesamte Inn Med; 1990 Sep; 45(18):547-9. PubMed ID: 1981291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Survival after myocardial infarction in the nineties. Results of a prospective registry and their implications as to identification of an increased risk of death and especially sudden death].
    Jordaens L; Tavernier R
    J Med Liban; 1999; 47(3):181-9. PubMed ID: 10550944
    [No Abstract]   [Full Text] [Related]  

  • 32. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
    Austin PC; Tu JV; Ko DT; Alter DA
    CMAJ; 2008 Oct; 179(9):901-8. PubMed ID: 18936455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systolic heart failure: a prothrombotic state.
    de Peuter OR; Kok WE; Torp-Pedersen C; Büller HR; Kamphuisen PW
    Semin Thromb Hemost; 2009 Jul; 35(5):497-504. PubMed ID: 19739040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
    Eagle KA; Kline-Rogers E; Goodman SG; Gurfinkel EP; Avezum A; Flather MD; Granger CB; Erickson S; White K; Steg PG
    Am J Med; 2004 Jul; 117(2):73-81. PubMed ID: 15234641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The secondary prevention of coronary disease: ACE inhibitors, adrenergic beta-blockers and statins for everyone? The arguments con].
    Simões L; Guimarães J; Fontes JP
    Rev Port Cardiol; 2000 Jan; 19(1):107-13. PubMed ID: 10731796
    [No Abstract]   [Full Text] [Related]  

  • 36. [Betablocker therapy in acute myocardial infarction].
    Danchin N; Angioi M; Preiss JP; Jacquemin L; Houriez P
    Arch Mal Coeur Vaiss; 1998 Apr; 91 Spec No 2():43-7. PubMed ID: 9749276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The treatment of myocardial infarction.
    Timmis GC; Terrien E
    J Interv Cardiol; 1995 Dec; 8(6 Suppl):730-51. PubMed ID: 10159764
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of STEMI in low- and middle-income countries.
    Baliga RR; Bahl VK; Alexander T; Mullasari A; Manga P; Dec GW; Narula J
    Glob Heart; 2014 Dec; 9(4):469-510. PubMed ID: 25592801
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute myocardial infarction.
    Danchin N; Urban P; De Benedetti E
    Clin Evid; 2003 Dec; (10):37-63. PubMed ID: 15555085
    [No Abstract]   [Full Text] [Related]  

  • 40. Outcomes of acute myocardial infarction in nonagenarians.
    Hovanesyan A; Rich MW
    Am J Cardiol; 2008 May; 101(10):1379-83. PubMed ID: 18471445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.